Jeffrey Stein Transaction History

Date Transaction Value Shares Traded Form
Jan 07 2026
SELL
Sale (or disposition) back to the issuer
$15,477,755 $221.5 p/Share
69,877
Dec 22 2025
SELL
Bona fide gift
-
5,425
Dec 19 2025
BUY
Bona fide gift
-
10,638
Dec 17 2025
BUY
Bona fide gift
-
2,244
Dec 10 2025
BUY
Bona fide gift
-
33,072
Jun 07 2024
BUY
Open market or private purchase
$105,680 $13.21 p/Share
8,000
Aug 08 2023
BUY
Open market or private purchase
$48,000 $0.96 p/Share
50,000
Mar 27 2023
BUY
Open market or private purchase
$52,000 $1.04 p/Share
50,000
Dec 31 2021
SELL
Bona fide gift
-
1,873
Dec 31 2021
BUY
Bona fide gift
-
937
Dec 10 2020
SELL
Other acquisition or disposition
-
658
Nov 10 2020
BUY
Open market or private purchase
$100,025 $40.01 p/Share
2,500
Sep 12 2017
BUY
Open market or private purchase
$49,838 $135.8 p/Share
367
Jun 05 2017
BUY
Open market or private purchase
$89,212 $118.95 p/Share
750
Mar 31 2017
BUY
Open market or private purchase
$99,975 $155.0 p/Share
645

Also insider at

PRTK
Paratek Pharmaceuticals, Inc. Healthcare
IDYA
IDEAYA Biosciences, Inc. Healthcare
JS

Jeffrey Stein

President & CEO
San Diego, CA

Track Institutional and Insider Activities on CDTX

Follow Cidara Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDTX shares.

Notify only if

Insider Trading

Get notified when an Cidara Therapeutics, Inc. insider buys or sells CDTX shares.

Notify only if

News

Receive news related to Cidara Therapeutics, Inc.

Track Activities on CDTX